津药药业(600488.SH)子公司复合磷酸氢钾注射剂拟中选第十二批全国药品集中采购

智通财经08-04

智通财经APP讯，津药药业(600488.SH)发布公告，近日，公司控股子公司津药和平(天津)制药有限公司参加了国家组织药品联合采购办公室组织的第十二批全国药品集中采购，复合磷酸氢钾注射剂拟中选此次集中采购。该药品拟中选价格为0.89元/支，采购周期自中选结果执行之日起至2029年12月31日。据悉，上述拟中选产品2025年度销售收入为1148.71万元，占公司2025年度营业收入比例为0.40%...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohunote.com/m/news/2656535912?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-08-04 16:09","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2656535912","market":"us","top_or_hot":-1,"title":"津药药业(600488.SH)子公司复合磷酸氢钾注射剂拟中选第十二批全国药品集中采购","media":"智通财经","content":"<div>\n<p>智通财经APP讯，津药药业(600488.SH)发布公告，近日，公司控股子公司津药和平(天津)制药有限公司参加了国家组织药品联合采购办公室组织的第十二批全国药品集中采购，复合磷酸氢钾注射剂拟中选此次集中采购。该药品拟中选价格为0.89元/支，采购周期自中选结果执行之日起至2029年12月31日。据悉，上述拟中选产品2025年度销售收入为1148.71万元，占公司2025年度营业收入比例为0.40%...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1475727.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>津药药业(600488.SH)子公司复合磷酸氢钾注射剂拟中选第十二批全国药品集中采购</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n津药药业(600488.SH)子公司复合磷酸氢钾注射剂拟中选第十二批全国药品集中采购\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-08-04 16:09 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1475727.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP讯，津药药业(600488.SH)发布公告，近日，公司控股子公司津药和平(天津)制药有限公司参加了国家组织药品联合采购办公室组织的第十二批全国药品集中采购，复合磷酸氢钾注射剂拟中选此次集中采购。该药品拟中选价格为0.89元/支，采购周期自中选结果执行之日起至2029年12月31日。据悉，上述拟中选产品2025年度销售收入为1148.71万元，占公司2025年度营业收入比例为0.40%...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1475727.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0102","symbol_name":"重组","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1475727.html","article_id":"2656535912","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2656535912","pubTimestamp":1785830973,"columns":[],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP讯，津药药业 发布公告，近日，公司控股子公司津药和平(天津)制药有限公司参加了国家组织药品联合采购办公室组织的第十二批全国药品集中采购，复合磷酸氢钾注射剂拟中选此次集中采购。据悉，上述拟中选产品2025年度销售收入为1148.71万元，占公司2025年度营业收入比例为0.40%;2026年一季度销售收入为91.57万元，占公司2026年一季度营业收入比例为0.15%。此次拟中选产品的中选价格与原销售价格相比有一定程度下降。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"600488":"津药药业","BK0102":"重组","BK0012":"证金概念","BK0028":"国家队","BK0239":"医药制造"},"translate_title":"Compound potassium hydrogen phosphate injection, a subsidiary of Jinyao Pharmaceutical (600488.SH), plans to be selected for the 12th batch of national centralized drug procurement","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"600488":1.5},"content_text":"智通财经APP讯，津药药业(600488.SH)发布公告，近日，公司控股子公司津药和平(天津)制药有限公司参加了国家组织药品联合采购办公室组织的第十二批全国药品集中采购，复合磷酸氢钾注射剂拟中选此次集中采购。该药品拟中选价格为0.89元/支，采购周期自中选结果执行之日起至2029年12月31日。据悉，上述拟中选产品2025年度销售收入为1148.71万元，占公司2025年度营业收入比例为0.40%;2026年一季度销售收入为91.57万元，占公司2026年一季度营业收入比例为0.15%。此次拟中选产品的中选价格与原销售价格相比有一定程度下降。若确定中选，签订采购合同并实施后，将进一步扩大该产品的销售，提高市场占有率，提升公司品牌影响力，促进公司制剂业务的进一步发展。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2656535912","isCrawlerRequest":true}